Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Neximmune Inc
NEXICurrent price
0.25 USD
-0.04 USD (-13.79%)
Last closed
0.21 USD
Company
www.neximmune.com
ISIN
US65344D1090
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
308 222 USD
Yield for 12 month
-91.07 %
1Y
3Y
5Y
10Y
15Y
NEXI
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland. Address: 9119 Gaither Road, Gaithersburg, MD, United States, 20877
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+2 120 558 USD
Current Year
-1 024 972 USD
Last Year
-1 495 345 USD
Current Quarter
–
Last Quarter
-114 912 USD
Key Figures NEXI
1 year
3 years
5 years
10 years
EBITDA
-16 375 748 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-72.7 %
PEG Ratio
–
Return On Equity TTM
-232.97 %
Wall Street Target Price
2 USD
Revenue TTM
–
Book Value
0.5 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-18.51 USD
Diluted Eps TTM
-18.51 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NEXI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NEXI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
19.10.2023
Dividend Date
–
Stock Valuation NEXI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.5251
Price Book MRQ
0.335
Financials NEXI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NEXI
For 52 weeks
0.2 USD
21 USD
50 Day MA
0.34 USD
Shares Short Prior Month
16 621
200 Day MA
3.46 USD
Short Ratio
2.26
Shares Short
15 988
Short Percent
1.3 %
BeatStart